by In2Pharma | Jul 13, 2026 | News
Europe The CMDh has agreed to remove the requirement to submit a cover letter for Type IA and Type IAin variation applications. This change took effect on 1 July 2026. To reflect this update, several guidance documents have been revised, including: Requirements on...
